Celcuity Long Term Deferred Assets (Quarterly) Analysis

Celcuity, Inc. (CELC)

107.45 +2.06 (+1.95%) USD | NASDAQ | Jan 21, 14:45

View Long Term Deferred Assets (Quarterly) for CELC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Olema Pharmaceuticals, Inc.	--
Replimune Group, Inc.	--
Arrowhead Pharmaceuticals, Inc.	--
Cidara Therapeutics, Inc.	--
Cogent Biosciences, Inc.	--